SIMILAR PATTERNS OF AMINO ACIDS FOR 4N09_B_ADNB401_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b0k | PROTEIN (ACONITASE) (Sus scrofa) |
PF00330(Aconitase)PF00694(Aconitase_C) | 5 | ASP A 454GLY A 451ALA A 461PHE A 326GLY A 436 | None | 0.92A | 4n09B-1b0kA:undetectable | 4n09B-1b0kA:19.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dgm | ADENOSINE KINASE (Toxoplasmagondii) |
PF00294(PfkB) | 7 | ASN A 20ASP A 24GLY A 68GLY A 69ASN A 73GLY A 315ASP A 318 | ADN A 375 ( 3.8A)ADN A 375 (-2.9A)ADN A 375 ( 4.5A)ADN A 375 (-2.9A)ADN A 375 ( 4.9A)ACY A 370 (-3.1A)ADN A 375 ( 3.1A) | 0.47A | 4n09B-1dgmA:41.5 | 4n09B-1dgmA:34.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dgm | ADENOSINE KINASE (Toxoplasmagondii) |
PF00294(PfkB) | 8 | ASP A 24LEU A 46GLY A 68GLY A 69ASN A 73CYH A 127GLY A 315ASP A 318 | ADN A 375 (-2.9A)NoneADN A 375 ( 4.5A)ADN A 375 (-2.9A)ADN A 375 ( 4.9A)ADN A 375 ( 4.2A)ACY A 370 (-3.1A)ADN A 375 ( 3.1A) | 0.62A | 4n09B-1dgmA:41.5 | 4n09B-1dgmA:34.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1geu | GLUTATHIONEREDUCTASE (Escherichiacoli) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | LEU A 334GLY A 16GLY A 15ALA A 317GLY A 140 | NoneNoneFAD A 451 (-3.5A)NoneFAD A 451 (-3.5A) | 1.01A | 4n09B-1geuA:4.8 | 4n09B-1geuA:22.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rk2 | RIBOKINASE (Escherichiacoli) |
PF00294(PfkB) | 5 | ASP A 16GLY A 41GLY A 42ASN A 46ASP A 255 | RIB A 311 (-2.8A)RIB A 311 (-3.3A)RIB A 311 (-3.4A)RIB A 311 (-3.3A)RIB A 311 (-3.1A) | 0.33A | 4n09B-1rk2A:33.4 | 4n09B-1rk2A:26.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tz6 | PUTATIVE SUGARKINASE (Salmonellaenterica) |
PF00294(PfkB) | 6 | ASP A 16GLY A 30GLY A 31ASN A 35GLY A 249ASP A 252 | AIS A 402 (-2.5A)AIS A 402 ( 4.2A)AIS A 402 (-3.8A)AIS A 402 (-3.9A)AIS A 402 ( 4.5A)AIS A 402 (-3.0A) | 0.53A | 4n09B-1tz6A:30.5 | 4n09B-1tz6A:24.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v19 | 2-KETO-3-DEOXYGLUCONATE KINASE (Thermusthermophilus) |
PF00294(PfkB) | 6 | LEU A 170GLY A 33GLY A 34ASN A 38GLY A 248ASP A 251 | None | 0.99A | 4n09B-1v19A:30.7 | 4n09B-1v19A:28.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vgp | 373AA LONGHYPOTHETICAL CITRATESYNTHASE (Sulfurisphaeratokodaii) |
PF00285(Citrate_synt) | 5 | LEU A 27GLY A 216GLY A 217ASN A 219GLY A 251 | None | 0.93A | 4n09B-1vgpA:undetectable | 4n09B-1vgpA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vm7 | RIBOKINASE (Thermotogamaritima) |
PF00294(PfkB) | 5 | ASP A 14GLY A 39GLY A 40ASN A 44ASP A 246 | None | 0.57A | 4n09B-1vm7A:31.9 | 4n09B-1vm7A:26.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2abq | FRUCTOSE 1-PHOSPHATEKINASE (Bacillushalodurans) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 246ASP A 249 | None | 1.15A | 4n09B-2abqA:26.7 | 4n09B-2abqA:24.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2afb | 2-KETO-3-DEOXYGLUCONATE KINASE (Thermotogamaritima) |
PF00294(PfkB) | 5 | LEU A 171GLY A 32GLY A 33ASN A 37ASP A 280 | None | 0.88A | 4n09B-2afbA:30.7 | 4n09B-2afbA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ajr | SUGAR KINASE, PFKBFAMILY (Thermotogamaritima) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 39GLY A 40ASN A 44GLY A 258ASP A 261 | NoneACT A 321 (-3.1A)ACT A 321 ( 4.3A)ACT A 321 (-3.9A)ACT A 321 (-3.9A)NoneNone | 1.03A | 4n09B-2ajrA:25.5 | 4n09B-2ajrA:25.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c49 | SUGAR KINASE MJ0406 (Methanocaldococcusjannaschii) |
PF00294(PfkB) | 6 | ASP A 17GLY A 42GLY A 43ASN A 47GLY A 244ASP A 247 | ADN A1301 (-2.8A)ADN A1301 (-3.4A)ADN A1301 (-3.3A)ADN A1301 (-3.4A)NoneADN A1301 (-2.9A) | 0.74A | 4n09B-2c49A:29.5 | 4n09B-2c49A:25.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f02 | TAGATOSE-6-PHOSPHATEKINASE (Enterococcusfaecalis) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 252ASP A 255 | NoneNoneNoneNoneNoneATP A 411 (-3.6A)ATP A 411 (-4.1A) | 1.07A | 4n09B-2f02A:26.4 | 4n09B-2f02A:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2go4 | UDP-3-O-[3-HYDROXYMYRISTOYL]N-ACETYLGLUCOSAMINEDEACETYLASE (Aquifexaeolicus) |
PF03331(LpxC) | 5 | LEU A 206GLY A 264ASN A 268GLY A 245ASP A 246 | None | 1.01A | 4n09B-2go4A:undetectable | 4n09B-2go4A:21.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 9 | ASN A 14ASP A 18GLY A 63GLY A 64ASN A 68CYH A 123ALA A 136GLY A 297ASP A 300 | 89I A 500 (-4.0A)NoneNone89I A 500 (-3.5A)NoneNone89I A 500 (-3.4A)NoneNone | 0.77A | 4n09B-2i6bA:42.8 | 4n09B-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 7 | ASN A 14GLY A 63GLY A 64ASN A 68PHE A 170GLY A 297ASP A 300 | 89I A 500 (-4.0A)None89I A 500 (-3.5A)None89I A 500 (-3.8A)NoneNone | 0.58A | 4n09B-2i6bA:42.8 | 4n09B-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 9 | ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68CYH A 123ALA A 136GLY A 297ASP A 300 | None89I A 500 ( 4.8A)None89I A 500 (-3.5A)NoneNone89I A 500 (-3.4A)NoneNone | 0.70A | 4n09B-2i6bA:42.8 | 4n09B-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 6 | LEU A 40GLY A 64ASN A 68CYH A 123ALA A 136GLY A 297 | 89I A 500 ( 4.8A)89I A 500 (-3.5A)NoneNone89I A 500 (-3.4A)None | 1.34A | 4n09B-2i6bA:42.8 | 4n09B-2i6bA:40.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ibu | ACETYL-COAACETYLTRANSFERASE (Homo sapiens) |
PF00108(Thiolase_N)PF02803(Thiolase_C) | 5 | ASN A 158LEU A 67GLY A 97ALA A 64GLY A 183 | None | 1.02A | 4n09B-2ibuA:undetectable | 4n09B-2ibuA:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ify | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Bacillusanthracis) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ASP A 402GLY A 12GLY A 445ALA A 460GLY A 64 | MN A 601 (-2.4A)NoneNoneNoneNone | 0.84A | 4n09B-2ifyA:4.3 | 4n09B-2ifyA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jg5 | FRUCTOSE 1-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 246ASP A 249 | None | 1.18A | 4n09B-2jg5A:26.0 | 4n09B-2jg5A:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgv | TAGATOSE-6-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | ASP A 12GLY A 36GLY A 37ASN A 41ASP A 254 | None | 0.87A | 4n09B-2jgvA:25.8 | 4n09B-2jgvA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgv | TAGATOSE-6-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | GLY A 36GLY A 37ASN A 41GLY A 251ASP A 254 | None | 0.72A | 4n09B-2jgvA:25.8 | 4n09B-2jgvA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nwh | CARBOHYDRATE KINASE (Agrobacteriumfabrum) |
PF00294(PfkB) | 5 | ASP A 13GLY A 37GLY A 38ASN A 42ASP A 253 | NoneNone CL A 403 (-3.5A)NoneNone | 0.97A | 4n09B-2nwhA:26.4 | 4n09B-2nwhA:27.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2opv | KHSRP PROTEIN (Homo sapiens) |
PF00013(KH_1) | 5 | GLY A 14GLY A 13ASN A 12GLY A 71ASP A 72 | None | 0.98A | 4n09B-2opvA:undetectable | 4n09B-2opvA:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qcv | PUTATIVE5-DEHYDRO-2-DEOXYGLUCONOKINASE (Bacillushalodurans) |
PF00294(PfkB) | 6 | ASP A 22GLY A 43GLY A 44ASN A 48GLY A 269ASP A 272 | NoneNoneNoneNoneNonePGE A 332 (-3.6A) | 0.55A | 4n09B-2qcvA:31.2 | 4n09B-2qcvA:24.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r6r | CELL DIVISIONPROTEIN FTSZ (Aquifexaeolicus) |
PF00091(Tubulin)PF12327(FtsZ_C) | 5 | GLY 1 16GLY 1 17ASN 1 40GLY 1 66ASP 1 42 | GDP 1 339 (-3.5A)GDP 1 339 (-3.6A)GDP 1 339 ( 4.4A)NoneNone | 0.96A | 4n09B-2r6r1:8.6 | 4n09B-2r6r1:24.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z1a | 5'-NUCLEOTIDASE (Thermusthermophilus) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 381GLY A 380ASN A 378GLY A 486ASP A 487 | THM A6510 (-3.6A)THM A6510 (-4.1A)THM A6510 (-3.4A)NoneTHM A6510 (-2.4A) | 0.89A | 4n09B-2z1aA:undetectable | 4n09B-2z1aA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z8z | LIPASE (Pseudomonas sp.MIS38) |
PF00353(HemolysinCabind) | 5 | ASN A 441GLY A 403ASN A 405GLY A 382ASP A 400 | None CA A 621 ( 4.7A) CA A 621 (-2.8A) CA A 621 ( 4.8A) CA A 621 (-2.3A) | 0.98A | 4n09B-2z8zA:undetectable | 4n09B-2z8zA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bdk | D-MANNONATEDEHYDRATASE (Streptococcussuis) |
PF03786(UxuA) | 5 | ASP A 308LEU A 150GLY A 307ASN A 289GLY A 259 | None | 1.02A | 4n09B-3bdkA:undetectable | 4n09B-3bdkA:23.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3czm | L-LACTATEDEHYDROGENASE (Toxoplasmagondii) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | ASP A 143GLY A 288GLY A 193ASN A 165ASP A 168 | None | 1.00A | 4n09B-3czmA:5.9 | 4n09B-3czmA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dme | CONSERVED EXPORTEDPROTEIN (Bordetellapertussis) |
PF01266(DAO) | 5 | CYH A 198LEU A 367GLY A 182GLY A 183GLY A 218 | None | 0.95A | 4n09B-3dmeA:2.8 | 4n09B-3dmeA:24.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ewm | UNCHARACTERIZEDSUGAR KINASE PH1459 (Pyrococcushorikoshii) |
PF00294(PfkB) | 7 | ASP A 13LEU A 167GLY A 33GLY A 34ASN A 38GLY A 244ASP A 247 | None | 1.02A | 4n09B-3ewmA:29.8 | 4n09B-3ewmA:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3go7 | RIBOKINASE RBSK (Mycobacteriumtuberculosis) |
PF00294(PfkB) | 6 | ASP A 25GLY A 50GLY A 51ASN A 55GLY A 239ASP A 242 | RIB A 305 (-2.8A)RIB A 305 ( 3.7A)RIB A 305 (-3.1A)RIB A 305 (-3.2A)RIB A 305 ( 4.5A)RIB A 305 (-2.9A) | 0.52A | 4n09B-3go7A:28.7 | 4n09B-3go7A:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hj6 | FRUCTOKINASE (Halothermothrixorenii) |
PF00294(PfkB) | 6 | ASP A 33LEU A 188GLY A 54GLY A 55ASN A 59ASP A 275 | None | 0.80A | 4n09B-3hj6A:28.2 | 4n09B-3hj6A:24.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i3y | CARBOHYDRATE KINASE (Klebsiellapneumoniae) |
PF00294(PfkB) | 6 | ASP A 12GLY A 37GLY A 38ASN A 42GLY A 229ASP A 232 | None | 0.84A | 4n09B-3i3yA:26.3 | 4n09B-3i3yA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3in1 | UNCHARACTERIZEDSUGAR KINASE YDJH (Escherichiacoli) |
PF00294(PfkB) | 6 | ASP A 15GLY A 41GLY A 42ASN A 46GLY A 257ASP A 260 | NoneNoneNoneNone NA A 411 ( 4.9A)None | 0.73A | 4n09B-3in1A:31.2 | 4n09B-3in1A:26.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3isl | PURINE CATABOLISMPROTEIN PUCG (Bacillussubtilis) |
PF00266(Aminotran_5) | 5 | CYH A 328GLY A 152CYH A 321PHE A 316GLY A 97 | None | 0.92A | 4n09B-3islA:undetectable | 4n09B-3islA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ive | NUCLEOTIDASE (Escherichiacoli) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 373GLY A 372ASN A 370ALA A 217GLY A 471 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)SO4 A 604 (-3.7A)None | 1.02A | 4n09B-3iveA:undetectable | 4n09B-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ive | NUCLEOTIDASE (Escherichiacoli) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 373GLY A 372ASN A 370GLY A 471ASP A 472 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)NoneCTN A 603 (-2.7A) | 0.98A | 4n09B-3iveA:undetectable | 4n09B-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jty | BENF-LIKE PORIN (Pseudomonasprotegens) |
PF03573(OprD) | 5 | GLY A 312GLY A 311ALA A 321GLY A 153ASP A 151 | None | 0.97A | 4n09B-3jtyA:undetectable | 4n09B-3jtyA:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kfu | GLUTAMYL-TRNA(GLN)AMIDOTRANSFERASESUBUNIT A (Thermusthermophilus) |
PF01425(Amidase) | 5 | LEU E 106GLY E 143GLY E 144ALA E 64GLY E 79 | None | 0.95A | 4n09B-3kfuE:undetectable | 4n09B-3kfuE:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kzh | PROBABLE SUGARKINASE (Clostridiumperfringens) |
PF00294(PfkB) | 5 | GLY A 42GLY A 43ASN A 47GLY A 254ASP A 257 | None | 0.38A | 4n09B-3kzhA:28.3 | 4n09B-3kzhA:24.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 11 | ASN A 14ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68CYH A 122ALA A 135PHE A 168GLY A 297ASP A 300 | B4P A 349 ( 4.0A)B4P A 349 (-2.8A)NoneB4P A 349 ( 3.8A)B4P A 349 (-3.5A)B4P A 349 (-3.6A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-3.4A)B4P A 349 (-2.9A)B4P A 349 (-3.4A) | 0.54A | 4n09B-3looA:48.0 | 4n09B-3looA:36.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 7 | ASN A 14LEU A 40GLY A 64ASN A 68PHE A 168GLY A 299ASP A 300 | B4P A 349 ( 4.0A)NoneB4P A 349 (-3.5A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-3.3A)B4P A 349 (-3.4A) | 1.14A | 4n09B-3looA:48.0 | 4n09B-3looA:36.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 6 | GLY A 63ASN A 68CYH A 122ALA A 135GLY A 297ASP A 300 | B4P A 349 ( 3.8A)B4P A 349 (-3.6A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-2.9A)B4P A 349 (-3.4A) | 1.21A | 4n09B-3looA:48.0 | 4n09B-3looA:36.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mkt | MULTI ANTIMICROBIALEXTRUSION PROTEIN(NA(+)/DRUGANTIPORTER)MATE-LIKE MDR EFFLUXPUMP (Vibrio cholerae) |
PF01554(MatE) | 5 | GLY A 421GLY A 424ALA A 276PHE A 363GLY A 406 | None | 1.00A | 4n09B-3mktA:undetectable | 4n09B-3mktA:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ngm | EXTRACELLULAR LIPASE (Fusariumgraminearum) |
PF01764(Lipase_3) | 5 | LEU A 157GLY A 63GLY A 64ALA A 153GLY A 19 | None | 0.98A | 4n09B-3ngmA:undetectable | 4n09B-3ngmA:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3noq | THIJ/PFPI FAMILYPROTEIN (Pseudomonasfluorescens) |
PF01965(DJ-1_PfpI) | 5 | GLY A 150GLY A 151ALA A 123GLY A 70ASP A 17 | NoneNoneNHE A 501 ( 4.4A)NHE A 501 ( 4.7A)EDO A 604 ( 4.6A) | 0.86A | 4n09B-3noqA:4.7 | 4n09B-3noqA:22.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 8 | ASP A 17LEU A 39GLY A 62GLY A 63CYH A 123ALA A 136PHE A 169GLY A 296 | AP5 A 346 (-2.8A)NoneAP5 A 346 (-3.6A)AP5 A 346 (-3.5A)AP5 A 346 (-3.7A)AP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 (-3.2A) | 0.64A | 4n09B-3otxA:58.2 | 4n09B-3otxA:99.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 11 | CYH A 12ASN A 13ASP A 17LEU A 39GLY A 62GLY A 63ASN A 67CYH A 123ALA A 136PHE A 169ASP A 299 | AP5 A 346 (-3.6A)AP5 A 346 (-4.1A)AP5 A 346 (-2.8A)NoneAP5 A 346 (-3.6A)AP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 (-3.7A)AP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 ( 3.2A) | 0.19A | 4n09B-3otxA:58.2 | 4n09B-3otxA:99.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 8 | CYH A 12ASN A 13LEU A 39GLY A 63ASN A 67PHE A 169GLY A 298ASP A 299 | AP5 A 346 (-3.6A)AP5 A 346 (-4.1A)NoneAP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 (-3.4A)AP5 A 346 (-3.2A)AP5 A 346 ( 3.2A) | 1.06A | 4n09B-3otxA:58.2 | 4n09B-3otxA:99.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pl2 | SUGAR KINASE,RIBOKINASE FAMILY (Corynebacteriumglutamicum) |
PF00294(PfkB) | 6 | ASP A 19GLY A 40GLY A 41ASN A 45GLY A 261ASP A 264 | None | 0.60A | 4n09B-3pl2A:31.0 | 4n09B-3pl2A:26.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q1y | LIN2199 PROTEIN (Listeriainnocua) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 37GLY A 38CYH A 92GLY A 248ASP A 251 | None | 0.97A | 4n09B-3q1yA:26.4 | 4n09B-3q1yA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ry7 | RIBOKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | ASP A 14GLY A 40GLY A 41ASN A 45ASP A 254 | GOL A 401 (-3.1A)GOL A 401 ( 3.7A)GOL A 401 (-3.8A)GOL A 401 (-3.9A)None | 0.50A | 4n09B-3ry7A:29.2 | 4n09B-3ry7A:25.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3shw | TIGHT JUNCTIONPROTEIN ZO-1 (Homo sapiens) |
PF00595(PDZ)PF00625(Guanylate_kin)PF07653(SH3_2) | 5 | ASP A 517LEU A 487GLY A 516GLY A 439ALA A 483 | None | 0.96A | 4n09B-3shwA:undetectable | 4n09B-3shwA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tsw | TIGHT JUNCTIONPROTEIN ZO-1 (Homo sapiens) |
PF00595(PDZ)PF00625(Guanylate_kin)PF07653(SH3_2) | 5 | ASP A 517LEU A 487GLY A 516GLY A 439ALA A 483 | None | 0.99A | 4n09B-3tswA:undetectable | 4n09B-3tswA:25.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ubo | ADENOSINE KINASE (Sinorhizobiummeliloti) |
PF00294(PfkB) | 8 | ASN A 11ASP A 15LEU A 37GLY A 58GLY A 59ASN A 63GLY A 275ASP A 278 | ADN A 353 (-3.7A)ADN A 353 (-2.8A)NoneADN A 353 (-3.3A)ADN A 353 (-3.2A)ADN A 353 (-3.4A)ADN A 353 (-3.7A)ADN A 353 (-3.3A) | 0.64A | 4n09B-3uboA:39.3 | 4n09B-3uboA:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uqe | 6-PHOSPHOFRUCTOKINASE ISOZYME 2 (Escherichiacoli) |
PF00294(PfkB) | 5 | ASP A 14GLY A 38GLY A 39ASN A 43ASP A 256 | None | 0.76A | 4n09B-3uqeA:26.6 | 4n09B-3uqeA:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uqe | 6-PHOSPHOFRUCTOKINASE ISOZYME 2 (Escherichiacoli) |
PF00294(PfkB) | 5 | GLY A 38GLY A 39ASN A 43GLY A 253ASP A 256 | NoneNoneNoneATP A 401 ( 4.1A)None | 0.50A | 4n09B-3uqeA:26.6 | 4n09B-3uqeA:24.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vas | PUTATIVE ADENOSINEKINASE (Schistosomamansoni) |
PF00294(PfkB) | 9 | ASN A 14ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68PHE A 169GLY A 299ASP A 302 | ADN A 401 ( 4.0A)ADN A 401 (-2.7A)NoneADN A 401 ( 3.8A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 ( 3.8A)ADN A 401 (-2.9A) | 0.43A | 4n09B-3vasA:47.2 | 4n09B-3vasA:30.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vas | PUTATIVE ADENOSINEKINASE (Schistosomamansoni) |
PF00294(PfkB) | 6 | ASN A 14LEU A 40ASN A 68PHE A 169GLY A 301ASP A 302 | ADN A 401 ( 4.0A)NoneADN A 401 (-3.7A)ADN A 401 (-3.7A)NoneADN A 401 (-2.9A) | 1.23A | 4n09B-3vasA:47.2 | 4n09B-3vasA:30.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vth | HYDROGENASEMATURATION FACTOR (Caldanaerobactersubterraneus) |
PF00708(Acylphosphatase)PF01300(Sua5_yciO_yrdC)PF07503(zf-HYPF) | 5 | LEU A 474GLY A 407GLY A 406ALA A 471GLY A 740 | None | 1.01A | 4n09B-3vthA:undetectable | 4n09B-3vthA:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zwf | ZINCPHOSPHODIESTERASEELAC PROTEIN 1 (Homo sapiens) |
PF00753(Lactamase_B)PF12706(Lactamase_B_2) | 5 | CYH A 254LEU A 309GLY A 188CYH A 249GLY A 261 | None | 1.01A | 4n09B-3zwfA:undetectable | 4n09B-3zwfA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zyv | AOX3 (Mus musculus) |
PF00111(Fer2)PF00941(FAD_binding_5)PF01315(Ald_Xan_dh_C)PF01799(Fer2_2)PF02738(Ald_Xan_dh_C2)PF03450(CO_deh_flav_C) | 5 | LEU A 707GLY A 873GLY A 872ASN A 913ALA A 706 | NoneNone NA A2337 (-4.0A)NoneNone | 1.01A | 4n09B-3zyvA:undetectable | 4n09B-3zyvA:14.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4du5 | PFKB (Polaromonas sp.JS666) |
PF00294(PfkB) | 5 | LEU A 197GLY A 59ASN A 63GLY A 282ASP A 285 | None CL A 401 ( 3.8A)NoneNoneNone | 0.90A | 4n09B-4du5A:29.7 | 4n09B-4du5A:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e3a | SUGAR KINASE PROTEIN (Rhizobium etli) |
PF00294(PfkB) | 8 | ASN A 9ASP A 13LEU A 35GLY A 56GLY A 57ASN A 61GLY A 273ASP A 276 | ADN A 500 (-3.8A)ADN A 500 (-2.7A)NoneADN A 500 (-3.5A)ADN A 500 (-3.7A)ADN A 500 (-3.5A)ADN A 500 (-3.9A)ADN A 500 (-2.8A) | 0.55A | 4n09B-4e3aA:40.6 | 4n09B-4e3aA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e3a | SUGAR KINASE PROTEIN (Rhizobium etli) |
PF00294(PfkB) | 6 | ASN A 9LEU A 35GLY A 57ASN A 61GLY A 275ASP A 276 | ADN A 500 (-3.8A)NoneADN A 500 (-3.7A)ADN A 500 (-3.5A)NoneADN A 500 (-2.8A) | 1.23A | 4n09B-4e3aA:40.6 | 4n09B-4e3aA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e84 | D-BETA-D-HEPTOSE7-PHOSPHATE KINASE (Burkholderiacenocepacia) |
PF00294(PfkB) | 5 | ASP A 29GLY A 58GLY A 59GLY A 267ASP A 270 | M7B A 502 (-2.9A)M7B A 502 (-3.4A)M7B A 502 (-3.6A)M7B A 502 (-3.7A)M7B A 502 (-3.1A) | 0.94A | 4n09B-4e84A:26.9 | 4n09B-4e84A:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4emd | 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE (Mycobacteroidesabscessus) |
PF00288(GHMP_kinases_N)PF08544(GHMP_kinases_C) | 5 | ASP A 117GLY A 114GLY A 113ALA A 49GLY A 68 | NoneSO4 A 402 (-3.4A)SO4 A 402 (-3.8A)NoneNone | 0.98A | 4n09B-4emdA:undetectable | 4n09B-4emdA:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fms | PROBABLE PORIN (Pseudomonasaeruginosa) |
no annotation | 5 | ASP B 292GLY B 287PHE B 172GLY B 128ASP B 126 | BDP B 401 (-2.9A)NoneNoneBDP B 401 ( 4.4A)BDP B 401 (-2.8A) | 1.02A | 4n09B-4fmsB:undetectable | 4n09B-4fmsB:22.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gm6 | PFKB FAMILYCARBOHYDRATE KINASE (Listeria grayi) |
PF00294(PfkB) | 6 | LEU A 172GLY A 33GLY A 34ASN A 38GLY A 267ASP A 270 | NoneGOL A 401 ( 4.1A)GOL A 401 (-3.7A)GOL A 401 (-4.4A)GOL A 401 ( 4.5A)GOL A 401 (-3.0A) | 0.96A | 4n09B-4gm6A:29.2 | 4n09B-4gm6A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h1s | 5'-NUCLEOTIDASE (Homo sapiens) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 393GLY A 392ASN A 390GLY A 505ASP A 506 | None | 0.82A | 4n09B-4h1sA:undetectable | 4n09B-4h1sA:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oh1 | L-IDITOL2-DEHYDROGENASE ([Clostridium]scindens) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | LEU A 162GLY A 182GLY A 183ALA A 161GLY A 46 | NoneNoneNoneNoneOCS A 45 ( 2.4A) | 0.96A | 4n09B-4oh1A:5.6 | 4n09B-4oh1A:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oon | PENICILLIN-BINDINGPROTEIN 1A (Pseudomonasaeruginosa) |
PF00905(Transpeptidase)PF00912(Transgly)PF17092(PCB_OB) | 5 | LEU A 685GLY A 709GLY A 694ALA A 684GLY A 697 | NoneNoneNoneNone2U4 A 901 (-3.7A) | 0.98A | 4n09B-4oonA:undetectable | 4n09B-4oonA:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 6 | ASP A 11GLY A 29GLY A 30ASN A 34GLY A 246ASP A 249 | NoneNoneNoneNoneANP A 401 (-3.3A)ANP A 401 ( 4.3A) | 0.53A | 4n09B-4wjmA:30.0 | 4n09B-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 6 | CYH A 127ASP A 11GLY A 29GLY A 30ASN A 34ASP A 249 | NoneNoneNoneNoneNoneANP A 401 ( 4.3A) | 1.32A | 4n09B-4wjmA:30.0 | 4n09B-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 5 | GLY A 30ASN A 34ALA A 85GLY A 246ASP A 249 | NoneNoneNoneANP A 401 (-3.3A)ANP A 401 ( 4.3A) | 1.00A | 4n09B-4wjmA:30.0 | 4n09B-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 5 | LEU A 162GLY A 29GLY A 30ASN A 34ASP A 249 | NoneNoneNoneNoneANP A 401 ( 4.3A) | 0.92A | 4n09B-4wjmA:30.0 | 4n09B-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x8f | RIBOKINASE (Vibrio cholerae) |
PF00294(PfkB) | 5 | ASP A 13GLY A 38GLY A 39ASN A 43ASP A 252 | None | 0.54A | 4n09B-4x8fA:29.7 | 4n09B-4x8fA:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5az4 | FLAGELLAR HOOKSUBUNIT PROTEIN (Campylobacterjejuni) |
PF07196(Flagellin_IN)PF07559(FlaE) | 6 | LEU A 296GLY A 343GLY A 345ASN A 340ALA A 316ASP A 347 | None | 1.49A | 4n09B-5az4A:undetectable | 4n09B-5az4A:18.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c41 | RIBOKINASE (Homo sapiens) |
PF00294(PfkB) | 6 | ASP A 27GLY A 52GLY A 53ASN A 57GLY A 266ASP A 269 | NoneNoneNoneNoneACP A 401 ( 4.1A) NA A 403 ( 4.7A) | 0.54A | 4n09B-5c41A:32.5 | 4n09B-5c41A:25.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5da0 | SULPHATE TRANSPORTER (Deinococcusgeothermalis) |
PF00916(Sulfate_transp)PF01740(STAS) | 5 | LEU A 35GLY A 298GLY A 72ALA A 305GLY A 68 | None | 1.00A | 4n09B-5da0A:undetectable | 4n09B-5da0A:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ey7 | FRUCTOKINASE (Vibrio cholerae) |
PF00294(PfkB) | 5 | ASP A 30GLY A 44GLY A 45ASN A 49ASP A 266 | None | 0.44A | 4n09B-5ey7A:31.1 | 4n09B-5ey7A:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h7w | VENOM5'-NUCLEOTIDASE (Naja atra) |
no annotation | 5 | GLY A 393GLY A 392ASN A 390GLY A 506ASP A 507 | None | 0.85A | 4n09B-5h7wA:undetectable | 4n09B-5h7wA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h8y | SULFITE REDUCTASE[FERREDOXIN],CHLOROPLASTIC (Zea mays) |
PF01077(NIR_SIR)PF03460(NIR_SIR_ferr) | 5 | LEU A 497GLY A 543CYH A 494ALA A 496GLY A 553 | NoneSF4 A 701 (-4.4A)SF4 A 701 ( 2.2A)SF4 A 701 ( 3.9A)None | 0.90A | 4n09B-5h8yA:undetectable | 4n09B-5h8yA:20.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iof | SULPHATE TRANSPORTER (Deinococcusgeothermalis) |
PF00916(Sulfate_transp) | 5 | LEU A 35GLY A 298GLY A 72ALA A 305GLY A 68 | None | 1.00A | 4n09B-5iofA:undetectable | 4n09B-5iofA:23.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jwr | CIRCADIAN CLOCKPROTEIN KINASE KAIC (Thermosynechococcuselongatus) |
PF06745(ATPase) | 5 | ASN A 245LEU A 55GLY A 28GLY A 36ASP A 30 | None | 1.02A | 4n09B-5jwrA:4.6 | 4n09B-5jwrA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kgn | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Caenorhabditiselegans) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ASP A 426GLY A 38GLY A 469ALA A 484GLY A 89 | MN A 604 (-2.2A)NoneNoneNoneNone | 0.89A | 4n09B-5kgnA:3.5 | 4n09B-5kgnA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kva | CAFFEOYL-COAO-METHYLTRANSFERASE (Sorghum bicolor) |
PF01596(Methyltransf_3) | 5 | LEU A 115GLY A 197GLY A 198ALA A 94PHE A 173 | None | 1.02A | 4n09B-5kvaA:4.7 | 4n09B-5kvaA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o0j | ADP-DEPENDENTGLUCOKINASE (Pyrococcushorikoshii) |
no annotation | 5 | ASP A 37GLY A 114GLY A 115ALA A 204ASP A 443 | GLC A 503 (-2.7A)GLC A 503 (-3.5A)GLC A 503 (-3.7A)NoneGLC A 503 (-2.6A) | 0.79A | 4n09B-5o0jA:22.7 | 4n09B-5o0jA:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o0j | ADP-DEPENDENTGLUCOKINASE (Pyrococcushorikoshii) |
no annotation | 5 | ASP A 37LEU A 93GLY A 114GLY A 115ALA A 204 | GLC A 503 (-2.7A)NoneGLC A 503 (-3.5A)GLC A 503 (-3.7A)None | 0.59A | 4n09B-5o0jA:22.7 | 4n09B-5o0jA:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5od2 | BIFUNCTIONALADP-SPECIFICGLUCOKINASE/PHOSPHOFRUCTOKINASE (Methanocaldococcusjannaschii) |
no annotation | 5 | ASP A 28GLY A 106GLY A 107ALA A 201ASP A 442 | GLC A 501 (-2.7A)GLC A 501 (-3.2A)GLC A 501 (-3.7A)NoneGLC A 501 ( 2.6A) | 0.61A | 4n09B-5od2A:22.4 | 4n09B-5od2A:14.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5od2 | BIFUNCTIONALADP-SPECIFICGLUCOKINASE/PHOSPHOFRUCTOKINASE (Methanocaldococcusjannaschii) |
no annotation | 5 | ASP A 28GLY A 107ALA A 201GLY A 439ASP A 442 | GLC A 501 (-2.7A)GLC A 501 (-3.7A)NonePO4 A 504 (-3.1A)GLC A 501 ( 2.6A) | 0.89A | 4n09B-5od2A:22.4 | 4n09B-5od2A:14.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x4j | UNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
no annotation | 5 | GLY A 138GLY A 136ALA A 41GLY A 164ASP A 165 | None ZN A 501 ( 4.8A)NoneNone ZN A 501 (-2.3A) | 0.97A | 4n09B-5x4jA:3.5 | 4n09B-5x4jA:12.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xb6 | UNCHARACTERIZEDPROTEIN YCJY (Escherichiacoli) |
no annotation | 5 | LEU A 199GLY A 45GLY A 44ALA A 202GLY A 119 | None | 1.01A | 4n09B-5xb6A:3.6 | 4n09B-5xb6A:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cw5 | RIBOKINASE (Cryptococcusneoformans) |
no annotation | 5 | ASP A 16GLY A 41GLY A 42ASN A 46ASP A 273 | GOL A 400 (-2.8A)GOL A 400 (-3.5A)GOL A 400 (-3.3A)GOL A 400 (-3.3A)None | 0.33A | 4n09B-6cw5A:31.7 | 4n09B-6cw5A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cw5 | RIBOKINASE (Cryptococcusneoformans) |
no annotation | 5 | ASP A 16GLY A 42ASN A 46GLY A 270ASP A 273 | GOL A 400 (-2.8A)GOL A 400 (-3.3A)GOL A 400 (-3.3A)NoneNone | 0.67A | 4n09B-6cw5A:31.7 | 4n09B-6cw5A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f2t | - (-) |
no annotation | 5 | LEU A 345GLY A 333GLY A 329ALA A 342GLY A 375 | None | 1.00A | 4n09B-6f2tA:undetectable | 4n09B-6f2tA:undetectable |